FIELD: medicine.
SUBSTANCE: invention refers to using a polyurethane polymer as a drug delivery system to provide the biologically active risperidone delivery at a constant speed for a relatively long period of time, as well as to methods for using it.
EFFECT: system provides high biological compatibility and biological stability and is applicable as an implant in patients (humans and animals) for the risperidone delivery to tissues and organs.
25 cl, 13 dwg, 3 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LONG-TERM DEVICES WITH POLYURETHANE POLYMERS FOR DRUG DELIVERY AND PREPARING THEM | 2009 |
|
RU2508089C2 |
| IMPLANTED OCTREOTIDE DELIVERY DEVICE AND METHOD FOR USING IT | 2009 |
|
RU2549473C2 |
| INTRAVAGINAL DEVICE FOR DRUG DELIVERY | 2012 |
|
RU2607179C2 |
| INTRAVAGINAL DEVICE FOR CONTROLLED DELIVERY OF LUBRICANTS | 2011 |
|
RU2591786C2 |
| OCTREOTIDE DELIVERY FROM DRY DOSAGE FORMS | 2009 |
|
RU2518745C2 |
| DEVICE FOR DRUGS DELIVERY WITH THE DRUG PERMEABLE AND THE DRUGS DELIVERY METHOD | 2014 |
|
RU2666684C2 |
| OCTREOTIDE IMPLANT CONTAINING RELEASING SUBSTANCE | 2009 |
|
RU2521291C2 |
| OSMOTIC IMPLANT HAVING MEMBRANE AND MEANS FOR RETAINING THE MEMBRANE | 2002 |
|
RU2295359C2 |
| PREPARATION OF POLYLACTIDE-POLYGLYCOLIDE MICROPARTICLES CHARACTERISED BY SIGMOIDAL RELEASE PROFILE | 2014 |
|
RU2658004C2 |
| COMPOSITIONS OF PROLONGEDACTION WITH CONTROLLED RELEASE | 2003 |
|
RU2355385C2 |
